The peroxisome proliferator-activated receptor-γ 2 (PPAR-γ 2) Pro12Ala polymorphism is associated with decreased risk of advanced diabetic nephropathy in patients with type 2 diabetes mellitus (DM2)

被引：0
作者：
Caramori, ML
Canani, LH
Costa, L
Gross, JL
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
[21]   No association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 with diabetic nephropathy in Japanese diabetic subjects [J].
Tamemoto, H ;
Namai, K ;
Saitoh, T ;
Ishikawa, SE ;
Kawakami, M .
DIABETES, 2005, 54 :A206-A206
[22]   Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population [J].
Misbah Majid ;
Akbar Masood ;
Showkat Ahmad Kadla ;
Iqra Hameed ;
Bashir A. Ganai .
Biochemical Genetics, 2017, 55 :10-21
[23]   Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population [J].
Majid, Misbah ;
Masood, Akbar ;
Kadla, Showkat Ahmad ;
Hameed, Iqra ;
Ganai, Bashir A. .
BIOCHEMICAL GENETICS, 2017, 55 (01) :10-21
[24]   Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2:: Association to type 2 diabetes and response to a glucose tolerance test in a risk population for diabetes [J].
Temelkova-Kurktschiev, T ;
Hanefeld, M ;
Koehler, C ;
Henkel, E ;
Leonhardt, W ;
Pietzsch, J ;
Laakso, M .
DIABETES, 2002, 51 :A269-A269
[25]   The peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians [J].
Scacchi, Renato ;
Pinto, Alessandro ;
Gambina, Giuseppe ;
Rosano, Aldo ;
Corbo, Rosa Maria .
BRAIN RESEARCH, 2007, 1139 :1-5
[26]   A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-γ2 is associated with combined hyperlipidaemia in obesity [J].
Swarbrick, MM ;
Chapman, CML ;
McQuillan, BM ;
Hung, J ;
Thompson, PL ;
Beilby, JP .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (03) :277-282
[27]   An analysis of peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits [J].
Scacchi, R. ;
Pinto, A. ;
Rickards, O. ;
Pacella, A. ;
De Stefano, G. F. ;
Cannella, C. ;
Corbo, R. M. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2007, 17 (09) :632-641
[28]   Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk [J].
Wang, Wei ;
Shao, Yan ;
Tang, Shenhua ;
Cheng, Xianyong ;
Lian, Haifeng ;
Qin, Chengyong .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03) :4066-4072
[29]   Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with Type 2 diabetes [J].
Ahn, YM ;
Lee, BC ;
Kim, SI ;
Byun, SH ;
Ahn, SY ;
Doo, HK .
DIABETOLOGIA, 2004, 47 :A425-A425
[30]   Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes [J].
Kang, ES ;
Park, SY ;
Kim, HJ ;
Kim, CS ;
Ahn, CW ;
Cha, BS ;
Lim, SK ;
Nam, CM ;
Lee, HC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (02) :202-208
12345